Safinejad Kyumars, Darbouy Mojtaba, Kalantar Sayed Mahdi, Zeinali Sirus, Mirfakhraie Reza, Yadegar Leila, Houshmand Masoud
Fars Science and Research branch, Islamic Azad University, Shiraz, Iran.
Research & Clinical Centre for Infertility, Shahid Sadoughi Medical Sciences University Yazd, Yazd, Iran.
J Assist Reprod Genet. 2011 Nov;28(11):1087-90. doi: 10.1007/s10815-011-9632-7. Epub 2011 Oct 6.
To evaluate five common cystic fibrosis trans-membrane conductance regulator (CFTR) mutations (ΔF508, G542X, R117H, W1282X and N1303K) in the Iranian infertile men with noncongenital absence of vas deferens (CAVD) obstructive azoospermia.
The common CFTR gene mutations were tested on blood samples from 53 infertile men with non-CAVD obstructive azoospermia and 50 normal men as control individuals. Genomic DNA is extracted from the whole blood and the common CFTR mutations have been detected by the amplification refractory mutation system (ARMS) techniques.
The common CFTR mutations were found positive in 5/53)9.43%(for ΔF508 and 4/53)7.55%(for G542X mutation of all patients tested. Also, no CFTR mutations were detected in the normal men.
The common CFTR mutations were detected in 9/53(17%) infertile men with non-CAVD obstructive azoospermia. Pre-treatment CFTR mutation analysis remains critical to distinguish cystic fibrosis (CF) genotypes for men with non CAVD obstructive azoospermia.
评估伊朗非先天性输精管缺如(CAVD)梗阻性无精子症的不育男性中5种常见的囊性纤维化跨膜传导调节因子(CFTR)突变(ΔF508、G542X、R117H、W1282X和N1303K)。
对53例非CAVD梗阻性无精子症的不育男性和50例正常男性的血液样本进行常见CFTR基因突变检测。从全血中提取基因组DNA,采用扩增阻滞突变系统(ARMS)技术检测常见CFTR突变。
在所有检测患者中,常见CFTR突变中ΔF508在5/53(9.43%)患者中呈阳性,G542X突变在4/53(7.55%)患者中呈阳性。此外,正常男性中未检测到CFTR突变。
在53例非CAVD梗阻性无精子症的不育男性中,9例(17%)检测到常见CFTR突变。对于非CAVD梗阻性无精子症男性,治疗前CFTR突变分析对于区分囊性纤维化(CF)基因型仍然至关重要。